Verapamil Hydrochloride

Quick links

Choose a section

Quick links to important sections

Advertisements

Verapamil Hydrochloride

Selected form

Advertisements
Advertisements

Overview of Verapamil Hydrochloride

Property Description
Active ingredient Verapamil Hydrochloride
Forms Tablets, Extended-Release Capsules, Intravenous Solution
Pharmacological class Calcium Channel Blocker (Non-Dihydropyridine), Group IV Antiarrhythmic
General purpose Management of cardiac electrical stability and vascular resistance
Origin Synthetic compound (Phenylalkylamine derivative)

Verapamil Hydrochloride is a synthetic, prescription-only medication whose active ingredient, Verapamil Hydrochloride itself, is chemically classified as a phenylalkylamine. The drug is used to help manage cardiovascular conditions by acting on the heart and circulatory system. It is supplied as a single-ingredient product, available for both oral administration and intravenous (IV) injection in clinical settings.


What Type of Medicine is Verapamil Hydrochloride?

Verapamil Hydrochloride belongs to the major pharmacological class known as a Calcium Channel Blocker (CCB). This classification signifies its core function as a calcium ion influx inhibitor, often referred to as a slow-channel blocker. It is uniquely distinguished as a non-dihydropyridine CCB, an attribute that sets it apart from the more vascular-selective CCBs. Verapamil is clinically recognized for its ability to significantly influence the heart's electrical conduction system, which contributes directly to its distinct classification as a Group IV Antiarrhythmic agent.


General Purpose and Action Principle

The general purpose of Verapamil Hydrochloride is to stabilize and improve key functions of the cardiovascular system. It acts by modulating calcium movement to achieve a critical dual benefit: it helps control and stabilize certain rapid or irregular heart rhythms, and it simultaneously promotes the relaxation and widening of peripheral blood vessels. This combined action contributes to reducing the heart's workload and lowering vascular resistance throughout the circulatory system.

Regulatory References

  1. Pharmacological studies of Verapamil (NIH)
Advertisements

What side effects are possible with Verapamil Hydrochloride?

Possible Side Effects and Safety Information

Safety Profile Overview

Verapamil Hydrochloride's safety profile is dominated by its cardiovascular effects, particularly the risk of conduction disturbances and myocardial depression. It is contraindicated in several serious conditions, including severe left ventricular dysfunction, hypotension or cardiogenic shock, and certain pre-existing heart rhythm disorders like second- or third-degree AV block (unless a functioning pacemaker is present) and sick sinus syndrome.

Adverse Reactions

Common Adverse Reactions (observed in 1% to 10% of patients) typically include constipation, headache, dizziness, peripheral edema (swelling of the legs/ankles), nausea, and bradycardia (slow heart rate).

Serious Adverse Reactions reported in regulatory documents include severe hypotension, significant bradycardia, second- or third-degree AV block (which may progress to asystole), and the development or aggravation of congestive heart failure or pulmonary edema. Cases of hepatocellular injury, marked by elevated liver enzymes, have also been reported, necessitating prudent monitoring of liver function.

Safety Restrictions and Monitoring

Specific caution is required in elderly patients and those with hepatic impairment, as the drug’s elimination half-life may be significantly prolonged, potentially requiring dose reduction. The drug is also contraindicated for use in patients with atrial flutter or atrial fibrillation who possess an accessory bypass tract (e.g., Wolff-Parkinson-White syndrome) due to the risk of accelerating the ventricular rate and inducing ventricular fibrillation. Concomitant use with beta-blockers or other cardiodepressant drugs requires extreme caution due to the potential for additive negative effects on myocardial contractility and AV conduction.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Verapamil Hydrochloride constitutes a medical emergency and requires immediate medical attention. Regulators explicitly state that any suspected over-ingestion requires immediate contact with emergency services due to the risk of severe, life-threatening outcomes.

Documented Overdose Manifestations

Officially documented signs of overdose relate primarily to severe cardiovascular depression and central nervous system effects. Manifestations may include profound hypotension, critically slow heart rate (bradycardia), and serious cardiac conduction defects such as high-degree atrioventricular (AV) block or asystole. Central nervous system effects such as confusion, stupor, and coma are also documented. Overdose can lead to shock, cardiac arrest, and death.

Emergency Actions and Supportive Care

Management is strictly symptomatic and supportive. Regulatory information notes that no specific antidote is known; therefore, treatment involves necessary pharmacological support, such as the use of intravenous calcium salts. Continuous cardiac monitoring and prolonged hospital observation are required, particularly following ingestion of extended-release formulations due to the risk of delayed toxicity.

Population Considerations

Official labeling indicates that overdose in pediatric patients carries a risk of more rapid onset of severe cardiotoxicity. Patients with hepatic or renal impairment may also experience more prolonged effects.

Advertisements

Therapeutic Uses of Verapamil Hydrochloride

What Verapamil Hydrochloride Treats: Main Uses and Benefits

Verapamil Hydrochloride is relevant in contexts marked by increased discomfort or tension. The medication is commonly used across conditions presenting with acute episodes and situations involving recurrent or episodic manifestations, such as certain forms of hypertension, angina, and arrhythmias.


Easing Symptom Burden and Supporting Stability

Verapamil is commonly used across domains where additional symptomatic support is needed for symptoms related to physical discomfort and systemic imbalance. It is relevant for easing symptoms linked to organ-specific functional stress in conditions associated with acute or disruptive episodes.

In these clinical settings, the goal is to provide supportive relief. “It is often used when symptoms intensify and supportive relief is needed.” For symptomatic discomfort, the medicine may assist with maintaining functional stability and generally contributes to easing the overall symptom load during symptomatic periods. It may help patients cope more steadily with symptom fluctuations when symptoms become more noticeable.


Quick Fact: Support for Disruptive Symptoms

Advertisements

Eligibility and Restrictions for Use

Verapamil Hydrochloride is generally allowed for use in adults and is also indicated for certain tachycardias in neonates, infants, children, and adolescents. However, use is strictly contraindicated in several specific patient groups due to the risk of serious cardiac events.

Contraindicated Populations

Patients must not use this medicine if they have a known hypersensitivity to verapamil, severe left ventricular dysfunction, or conditions such as cardiogenic shock or severe hypotension (systolic pressure under 90 mmHg).

It is also forbidden in patients with certain heart rhythm defects, including Second- or Third-Degree AV Block or Sick Sinus Syndrome, unless a functioning artificial ventricular pacemaker is present. The drug is also contraindicated in patients with Atrial Flutter or Atrial Fibrillation who also have an accessory bypass tract (e.g., Wolff-Parkinson-White syndrome).

Restricted Use and Special Consideration

Use in patients with impaired hepatic function requires caution and a reduced initial dose, as the drug’s metabolism is significantly delayed. Patients with renal impairment should also be monitored closely. The drug is not recommended in the first and second trimesters of pregnancy, but use in the third trimester is permitted only when clearly indicated by a healthcare professional.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Verapamil Hydrochloride is determined by its documented roles as an inhibitor of the CYP3A4 enzyme and the P-glycoprotein (P-gp) transporter, alongside its potent additive pharmacodynamic effects on the heart.

Interaction Scope and Constraints

Interacting Product Categories:

  • Antiarrhythmics (e.g., oral and intravenous Beta-blockers, Quinidine)
  • Statins (e.g., Simvastatin, Lovastatin), mTOR Inhibitors (e.g., Sirolimus)
  • CYP3A4 Inhibitors and Inducers (e.g., Ritonavir, Rifampin)

Officially Documented Restrictions:

  • Co-administration with Ivabradine is classified as contraindicated in regulatory documents.
  • Intravenous Beta-adrenergic blocking drugs must not be administered in close proximity (within a few hours) to intravenous Verapamil.
  • Timing rules mandate that Disopyramide must not be administered within 48 hours before or 24 hours after Verapamil.
  • Statin doses are restricted: Simvastatin must not exceed 10 mg daily and Lovastatin must not exceed 40 mg daily.

Key Interaction Outcomes:

  • Verapamil significantly increases the serum concentration of Digoxin (by 50% to 75%), requiring monitoring.
  • The combination with oral Beta-blockers is documented to cause additive cardiovascular depressant effects, including risk of AV block and profound bradycardia.
  • Grapefruit Juice may increase Verapamil concentrations, and Verapamil is documented to increase Alcohol (Ethanol) blood levels.

Population-Specific Notes:

  • Metabolism is delayed in patients with Hepatic Impairment, which prolongs the effects of Verapamil.

Connection to the overall interaction profile: This profile is defined by its role as a metabolic inhibitor and its additive cardiac effects, which leads to regulatory requirements for formal contraindications and constraints on co-administered agents to prevent documented increases in drug exposure and severe pharmacodynamic effects.

Advertisements

Mechanism of Action

Verapamil Hydrochloride exerts its pharmacodynamic effects by acting as a slow-channel blocker, specifically inhibiting the influx of calcium ions (Ca^2+) through the Voltage-dependent L-type calcium channels (CaV 1.2). This interaction is voltage- and frequency-dependent, preferentially targeting cells that are depolarized or rapidly firing.

This mechanism operates across three critical cardiovascular domains. In the Atrioventricular (AV) node, Ca^2+ inhibition prolongs the effective refractory period, resulting in a decrease in conduction velocity (negative dromotropy) and a decrease in spontaneous firing rate (negative chronotropy). Concurrently, the blockade of L-type channels on arteriolar smooth muscle cells interrupts excitation-contraction coupling. This action leads directly to vasodilation and a subsequent reduction in systemic vascular resistance and arterial afterload on the heart. Additionally, Verapamil acts on myocardial contractile cells, reducing Ca^2+ availability for contraction, which results in an intrinsic negative inotropic effect.

Advertisements

Dosage and Administration Information

Official Administration Guidelines

Verapamil Hydrochloride is used via two approved administration routes: oral intake for chronic management, and intravenous (IV) injection for acute clinical needs. The dosing schedule differs fundamentally based on the pharmaceutical form. Immediate-release oral tablets are typically administered in divided doses, two to four times daily, while extended-release formulations are designated for once daily use. The total adult daily dose may be adjusted upward over time, typically at weekly intervals, but should generally not exceed 480 mg per day.

For oral administration, the drug is generally taken with or without food. However, it is a key instruction that extended-release tablets and capsules must not be crushed, broken, or chewed to preserve the intended release profile. As a specific instruction for use, concurrent consumption of grapefruit juice should be avoided.

The intravenous form is strictly reserved for supervised clinical settings. The injection must be administered slowly over a minimum period of at least two minutes—a time frame extended to at least three minutes when treating older adults—and requires continuous monitoring. Dosing also includes specific population adjustments: patients with hepatic impairment require a significantly reduced initial dose, often starting at one-third or less of the normal dose. Long-term use should not be ended abruptly; a gradual dosage tapering is advised.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Verapamil Hydrochloride

Evidence for use in High Blood Pressure (Hypertension) Studies

Research has explored the use of Verapamil Hydrochloride in conditions characterized by systemic or functional imbalance, such as high blood pressure, by conducting large-scale randomized controlled trials (RCTs) and long-term observational cohort studies. These studies were designed to track and measure outcomes related to blood pressure readings and the overall incidence of major cardiovascular events, such as stroke, over defined time intervals.

Findings describe patterns observed in the studies where blood pressure measurements showed measured differences in the observed populations. Long-term comparative research tracked patterns regarding the incidence of major cardiovascular events that were associated with individuals receiving the studied medication. The evidence is limited regarding the volume of dedicated long-term research for major cardiovascular outcomes solely in patients with uncomplicated high blood pressure.


Evidence for use in Angina Pectoris (Chest Discomfort) Studies

Verapamil Hydrochloride was evaluated in research exploring outcomes related to physical discomfort, specifically for conditions involving periods of heightened symptoms, such as angina pectoris. The research includes short-term and intermediate-term randomized controlled trials and systematic reviews.

Trials reported patterns showing measured patterns related to the frequency of angina episodes across the studied populations. Research highlights changes measured during the study period related to functional measures, such such as patterns in the time participants could exercise before reporting discomfort. Evidence for this indication is categorized as consistent in regulatory research summaries, but there is limited information available for long-term outcomes such as prevention of mortality or myocardial infarction specifically in uncomplicated angina patients.


Evidence for use in Irregular Heart Rhythms (Arrhythmias) Studies

Research was conducted to examine temporary physiological imbalance associated with certain irregular heart rhythms, known as supraventricular tachycardias (SVT). Research focused on its acute use is based on specific acute-setting studies, but comparative evidence is lacking regarding long-term clinical outcomes when this medication is placed head-to-head against other pharmaceutical agents used for the chronic control of heart rate and rhythm.

Key Studies & References

  1. Effect of verapamil on the prognosis of patients with early postinfarction electrical or mechanical complications. The Danish Verapamil Infarction Trial II (DAVIT II)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Verapamil Hydrochloride (FAQ)

Q: What is the main reason a doctor would prescribe Verapamil Hydrochloride?

According to official regulatory documents, Verapamil Hydrochloride is indicated for the treatment of essential hypertension (high blood pressure), angina (chest pain), and the control of certain irregular heart rhythms (arrhythmias). This medication is indicated for the management of these specific cardiovascular conditions.

Q: What should I expect the first week after starting Verapamil Hydrochloride?

When starting the medication, official information indicates that common initial side effects, such as headache, constipation, or dizziness, may occur. Official documentation indicates that dosage adjustments by a healthcare professional are often made at weekly intervals based on individual response.

Q: Are there any common long-term side effects of Verapamil Hydrochloride I should know about?

Official warnings emphasize potential long-term risks such as developing or worsening congestive heart failure. Because the medication can affect liver function, official safety documents indicate that monitoring of liver enzyme levels may be relevant for patients on long-term treatment.

Q: Can Verapamil Hydrochloride interact with herbal supplements?

According to its pharmacological profile, Verapamil is known to inhibit the CYP3A4 enzyme in the body, which is responsible for metabolizing many substances. This means that Verapamil can potentially interact with other substances or herbal supplements that are also processed by this enzyme. Consultation with a healthcare professional regarding all supplements is relevant because of this potential interaction.

Q: Is Verapamil Hydrochloride safe to use if I have kidney problems?

Official regulatory information indicates that impaired kidney function generally does not affect the elimination of Verapamil Hydrochloride significantly. However, official documentation states that close monitoring by a healthcare professional should occur for individuals with kidney impairment.

Q: Do I need to check my pulse rate regularly while taking this medication?

Because this medication is documented to slow the heart's electrical activity, it commonly causes a slow heart rate, or bradycardia. Official safety information indicates that heart rate monitoring is relevant for some patients due to the possibility of bradycardia and changes in heart conduction.

Q: Can older adults take Verapamil Hydrochloride safely?

Official regulatory guidelines indicate that older adults can take Verapamil Hydrochloride, but caution is necessary because they may experience higher blood levels of the drug due to differences in metabolism. Official guidance notes that due to potential metabolic differences, the dosage for older adults may require adjustment to prevent high blood levels of the drug.

Q: How does the extended-release form of Verapamil Hydrochloride differ from the immediate-release form?

The main difference lies in how the medication is released into the body. Immediate-release (IR) forms are quickly absorbed and typically administered in divided doses throughout the day. Extended-release (ER) forms release the medication slowly over a prolonged period and are generally designated for once-daily use.

Q: Are there specific symptoms that require immediate medical attention while taking Verapamil Hydrochloride?

Serious adverse events documented in official warnings may manifest as certain symptoms. These include signs of severe hypotension (like fainting or severe lightheadedness) and the potential development or aggravation of congestive heart failure, which can present as sudden, severe swelling or difficulty breathing.

Q: Is Verapamil Hydrochloride a common treatment for atrial fibrillation?

Official indications state that Verapamil Hydrochloride is used for controlling the heart's rate at rest and during stress in patients with chronic atrial flutter or atrial fibrillation. However, it is contraindicated (must not be used) in patients who also have an accessory bypass tract in the heart.

Q: What does 'calcium channel blocker' mean in simple terms?

Verapamil belongs to the class of medications called calcium channel blockers, which act as a calcium ion influx inhibitor. In simple terms, this means it works by blocking the movement of calcium into the cells of the heart and blood vessel walls. This action helps to relax the blood vessels and also slows down certain electrical signals within the heart.

Q: Are there any food restrictions besides grapefruit when taking Verapamil Hydrochloride?

Official administration guidelines state that the medication can generally be taken with or without food. The main food-related restriction noted in regulatory documents is the avoidance of grapefruit juice, which can increase the drug's concentration in the body.

Q: Is Verapamil Hydrochloride considered a 'first-line' treatment for any conditions?

The regulatory documents strictly define the conditions for which Verapamil Hydrochloride is an approved treatment, such as hypertension and certain arrhythmias. However, determining if a drug is a 'first-line' treatment—meaning a preferred initial choice—is a matter of broader clinical practice guidelines, which are separate from the core drug label.

Q: Can Verapamil Hydrochloride affect blood test results?

Yes, official safety information indicates that Verapamil Hydrochloride has been associated with temporary or persistent elevations of liver enzymes in some patients. This possibility is why monitoring of liver function by a healthcare professional is considered necessary.

Q: What are the rules about using Verapamil Hydrochloride during pregnancy or breastfeeding?

For pregnancy, official documents classify the drug as Category C, meaning it should only be used if the potential benefit to the mother justifies the potential risk to the fetus. Regarding breastfeeding, the medication is known to be excreted into human milk, necessitating a decision to either discontinue nursing or discontinue the medication.

Q: Is Verapamil Hydrochloride used for chronic or acute conditions?

According to administration guidelines, Verapamil Hydrochloride is utilized for both chronic and acute conditions. The oral forms (tablets and capsules) are typically prescribed for long-term, chronic management, such as for hypertension or angina. The intravenous (IV) form is reserved for the acute treatment of rapid heart rhythms in a clinical setting.

Q: Does taking Verapamil Hydrochloride affect my ability to drive or operate machinery?

Official product information notes that because the medication can cause dizziness or drowsiness, a patient's reaction time may be impaired. Official warnings state that activities requiring full mental alertness, such as driving or operating heavy machinery, should be avoided until an individual knows how the drug affects them.

Q: What happens if I miss a dose of Verapamil Hydrochloride?

Official patient information advises that if you miss a dose, you should take it as soon as you remember. However, official patient information states that if it is close to the time for the next scheduled dose, the missed dose should be skipped entirely. Regulatory instructions warn against taking two doses at the same time.

Q: Is Verapamil Hydrochloride associated with fatigue or tiredness?

Yes, official regulatory documents list fatigue and tiredness as adverse reactions that have been commonly reported in patients during clinical trials.

Q: Is there a generic version of Verapamil Hydrochloride available?

According to drug listing information from government sources, Verapamil Hydrochloride is widely available as a generic drug. It is supplied in both immediate-release tablets and extended-release capsules or tablets.

Q: Can Verapamil Hydrochloride be taken with common pain relievers like ibuprofen?

Official interaction data indicates that non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen may potentially reduce the blood pressure lowering effect of Verapamil. Official sources indicate this combination requires caution and monitoring because of the potential for NSAIDs like ibuprofen to reduce the blood pressure lowering effect of Verapamil.

Q: Does the medicine come in different strengths?

Yes, the medication is manufactured and supplied in a variety of oral strengths to suit different therapeutic needs. Regulatory documents list strengths such as 40 mg, 80 mg, 120 mg, 180 mg, and 240 mg tablets or capsules.

Q: Can Verapamil Hydrochloride affect sleep?

While specific sleep disorders are not frequently listed as a common adverse reaction, official data reports Central Nervous System (CNS) effects like dizziness and headache. These common effects could indirectly influence the quality of sleep in some individuals.

Q: Are there different brand names for Verapamil Hydrochloride?

Yes, Verapamil Hydrochloride is the generic name for the active ingredient, and it is marketed under several brand names globally. These include, but are not limited to, Calan, Calan SR, Verelan, Verelan PM, and Isoptin.

Advertisements

How should Verapamil Hydrochloride be stored and disposed of?

Verapamil hydrochloride must be stored and disposed of according to specific regulatory requirements to maintain product stability and safety.

Storage Conditions

Official instructions mandate storing the medicine at Controlled Room Temperature, typically 20^circ to 25 C (68^circ to 77 F). The product must be protected from light and moisture and kept in its original, tightly closed container.

Handling and Safety

The injectable solution must not be frozen, as this affects its integrity. A critical safety requirement is that all forms of verapamil hydrochloride must be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired verapamil hydrochloride should be disposed of according to local requirements, often through a drug take-back program. It must not be flushed down toilets or poured into drains.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Verapamil Hydrochloride found in:

A-Z Index: